Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131515) titled 'Clinical Observation Study on Adalimumab Treatment for SAPHO Syndrome' on Sept. 3.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Fujian Medical University
Condition:
synovitis-acne-pustulosis-hyperostosis-osteomyelitis syndrome
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-03
Target Sample Size: Adalimumab treatment group:5;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=327738
Disclaimer: Curated by HT Syndication....